Neeraj Agarwal: Taking the microbiome modulation in cancer therapy to the next level

Neeraj Agarwal shared a post on X:

“Taking the microbiome modulation in cancer therapy to the next level.

Stellar talks on role of fecal microbiome transplant, CBM-588, Camu-camu, and diet by Genitourinary Cancer Research Team at City of Hope fellows Miguel Zugman, Regina Barragan-Carrillo and Salvador Jaime-Casas in SWOG Cancer Research Network meeting. Outstanding mentorship by Sumanta K. Pal.”

Neeraj Agarwal is a Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), University of Utah. He also directs the Genitourinary Oncology (GU) Program, and the Center of Investigational Therapeutics (CIT) at the HCI. Dr. Agarwal is an Advisor to the Oncology Drug Advisory Committee and the United States Food and Drug Administration, leads early therapeutics in the SWOG genitourinary cancers committee, and is the Chief Editor of ASCO Daily News.